I sold out entirely, mainly due to dodgy market conditions and a little frustration with CUV sp. Maybe a foolish move, but Neuren is travelling along not too bad. Hoping to jump back over to Clinuvel early next year if conditions are favourable. Clinuvel has a lot on its plate coming up with XP and AIS so I expect lots of potential medium term. Investors have the luxury of two attractive biotechs to choose from in Neuren and CUV so a bet each way wouldn’t go astray either. It will come down to timing for me whether I can capitalise on both early next year.
I sold out entirely, mainly due to dodgy market conditions and a...
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.40 |
Change
0.030(0.22%) |
Mkt cap ! $678.0M | |||
| Open | High | Low | Value | Volume |
| $13.51 | $13.62 | $13.30 | $321.6K | 23.90K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 195 | $13.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.40 | 38 | 4 |
View Market Depth
| Last trade - 12.01pm 26/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |